Commentary
JAK inhibitors: Unveiling varicella and herpes risks in atopic dermatitis
Defne Baskurt,
Defne Baskurt
Department of Dermatology, University of California, San Francisco, CA, USA
Search for more papers by this author Seçil Vural,
Corresponding Author
Seçil Vural
Department of Dermatology and Venereology, Koç University School of Medicine, İstanbul, Turkey
Correspondence
Seçil Vural
Department of Dermatology and Venereology
School of Medicine
Koç University
Davutpaşa Cad, No. 4
Topkapı
Istanbul 34010
Turkey
E-mail: [email protected]
Search for more papers by this author
Defne Baskurt,
Defne Baskurt
Department of Dermatology, University of California, San Francisco, CA, USA
Search for more papers by this author Seçil Vural,
Corresponding Author
Seçil Vural
Department of Dermatology and Venereology, Koç University School of Medicine, İstanbul, Turkey
Correspondence
Seçil Vural
Department of Dermatology and Venereology
School of Medicine
Koç University
Davutpaşa Cad, No. 4
Topkapı
Istanbul 34010
Turkey
E-mail: [email protected]
Search for more papers by this author
First published: 11 November 2024
No abstract is available for this article.
References
- 1Ireland PA, Verheyden M, Jansson N, Sebaratnam D, Sullivan J. Infection risk with JAK inhibitors in dermatoses: a meta-analysis. Int J Dermatol. 2024. https://doi.org/10.1111/ijd.17501. Epub ahead of print.
- 2Virtanen A, Spinelli FR, Telliez JB, O'Shea JJ, Silvennoinen O, Gadina M. JAK inhibitor selectivity: new opportunities, better drugs? Nat Rev Rheumatol. 2024; 20(10): 649–665.
- 3Wu SE, Chen YH, Chung CH, Wu GJ, Tsao CH, Sun CA, et al. Atopic dermatitis as a risk factor for herpes zoster infection independent of treatment: a nationwide population-based cohort study. Dermatitis. 2023; 34(3): 241–249.
- 4Utama A, Wijesinghe R, Thng S. Janus kinase inhibitors and the changing landscape of vitiligo management: a scoping review. Int J Dermatol. 2024; 63(8): 1020–1035.
- 5Castro LGM. JAK inhibitors: a novel, safe, and efficacious therapy for pyoderma gangrenosum. Int J Dermatol. 2023; 62(8): 1088–1093.
